Clinical Trials for Advanced Pancreatic Cancer

Find clinical trials for advanced pancreatic cancer. Discover research opportunities and treatment options in your area.

15 Active Trials Found

Showing 15 trials on this page

Page 1 of 1

Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer

NCT ID: NCT07006077

This clinical trial is testing a new treatment called hV01, which is an injection of a modified virus designed to help fight advanced pancreatic cancer. The main goal is to see if hV01 can effectiv...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China

A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China

NCT ID: NCT07026123

This clinical trial is studying a treatment called liposomal irinotecan (brand name Onivyde®) combined with other medicines, to see how well it works and how safe it is for people in China who have...

Not yet recruiting

Type: observational Locations: Shanghai, , China

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

NCT ID: NCT06821503

This clinical trial is exploring a new treatment option for patients with advanced pancreatic cancer. The study is looking at a combination of a medication called LM-108, along with penpulimab and ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shenyang, Liaoning, China, Harbin, Heilongjiang, China +14 more

APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma

NCT ID: NCT04643405

**Summary of the Clinical Trial: APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma** This clinical trial is exploring a new treatment for advanced pancreatic cancer, specifically lo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

NCT ID: NCT06492941

This clinical trial is studying a treatment called Docetaxel for Injection (Albumin Bound) for patients with advanced pancreatic cancer. The goal is to see if this treatment, when combined with the...

Not yet recruiting

Phase: PHASE3 Type: interventional

1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma

NCT ID: NCT04098081

This clinical trial is studying a medication called galeterone, both on its own and in combination with another drug called gemcitabine, to see how effective it is for patients with advanced pancre...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States

SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer

NCT ID: NCT06422156

This clinical trial is exploring a new treatment approach for patients with locally advanced pancreatic cancer, which is a type of cancer that cannot be surgically removed. The study is looking at ...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD

NCT ID: NCT06329947

This clinical trial is studying a new treatment option for patients with advanced pancreatic cancer who have not responded to their first-line chemotherapy. The researchers want to see if a combina...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, , China

Olaparib in PALB2 Advanced Pancreatic Cancer

NCT ID: NCT06078787

This clinical trial is exploring the use of a medication called Olaparib for patients with advanced pancreatic cancer that is linked to a specific gene mutation known as PALB2. The study is designe...

Recruiting

Phase: PHASE2 Type: interventional Locations: Modena, , Italy

A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer

NCT ID: NCT06111274

This clinical trial is studying a new treatment called Pimicotinib (ABSK021) for patients with advanced pancreatic cancer. The researchers want to find out if Pimicotinib is safe to use alongside c...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chengdu, , China, Chengdu, Sichuan, China +4 more

IMC001 for Clinical Research on Advanced Digestive System Malignancies

NCT ID: NCT05028933

This clinical trial is studying a new treatment called IMC001, which uses modified immune cells (T cells) to target certain types of advanced cancer in the digestive system, including liver, colore...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China, Hangzhou, , China

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

NCT ID: NCT05580445

This clinical trial is investigating a combination of three treatments—CT-707, toripalimab, and gemcitabine—for patients with advanced pancreatic cancer. The study aims to find out how safe these t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

NCT ID: NCT05916261

This clinical trial is exploring a new treatment for patients with advanced pancreatic cancer using a personalized tumor vaccine called mRNA-0217/S001. The goal is to see how safe and well-tolerate...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Qionghai, Hainan, China

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

NCT ID: NCT05380414

This clinical trial is focused on patients who have advanced or metastatic pancreatic cancer. The goal is to implement a special screening program that looks at the unique characteristics of each p...

Recruiting

Phase: NA Type: interventional Locations: Lyon, , France

Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer

NCT ID: NCT05162118

This clinical trial is investigating a new treatment called VG161 for patients with advanced pancreatic cancer. VG161 is an experimental therapy that combines a modified virus with a medication cal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions